Patient-derived head and neck cancer organoids allow treatment stratification and serve as a tool for biomarker validation and identification
Key Points
Key points are not available for this paper at this time.
Abstract
This work was funded by Oncode PoC 2018-P0003.
اسأل الذكاء الاصطناعي
Like
Bookmark
Share
View Full Paper
اسأل الذكاء الاصطناعي
Like
Bookmark
Share
View Full Paper
Patient-derived head and neck cancer organoids allow treatment stratification and serve as a tool for biomarker validation and identification | Synapse